Table 3. Adjusted hazard ratios (95% confidence intervals) for all-cause mortality associated with sleep-disordered breathing,stratified by sex and age in the Sleep Heart Health Study.
Apnea–Hypopnea Index (Events/h) | N | Person–Years | Deaths | Mortality Ratea | Model 1b | Model 2c | Model 3d |
Men ≤70 y | |||||||
<5.0 | 985 | 8,220 | 91 | 11.1 | 1.00 | 1.00 | 1.00 |
5.0–14.9 | 694 | 5,697 | 82 | 14.4 | 1.10 (0.81–1.48) | 1.16 (0.85–1.58) | 1.24 (0.90–1.71) |
15.0–29.9 | 322 | 2,623 | 47 | 17.9 | 1.37 (0.96–1.95) | 1.44 (1.00–2.08) | 1.45 (0.98–2.14) |
≥30.0 | 168 | 1,355 | 28 | 20.7 | 1.67 (1.09–2.55) | 1.88 (1.19–2.95) | 2.09 (1.31–3.33) |
Men >70 y | |||||||
<5.0 | 277 | 2,055 | 125 | 60.8 | 1.00 | 1.00 | 1.00 |
5.0–14.9 | 282 | 2,176 | 111 | 51.0 | 0.86 (0.67–1.11) | 0.89 (0.69–1.16) | 0.92 (0.70–1.20) |
15.0–29.9 | 140 | 1,029 | 67 | 65.1 | 1.18 (0.87–1.58) | 1.25 (0.92–1.70) | 1.23 (0.90–1.68) |
≥30.0 | 74 | 517 | 36 | 69.6 | 1.16 (0.80–1.69) | 1.25 (0.85–1.83) | 1.27 (0.86–1.86) |
Women ≤70 y | |||||||
<5.0 | 1641 | 13,902 | 90 | 6.5 | 1.00 | 1.00 | 1.00 |
5.0–14.9 | 527 | 4,448 | 40 | 9.0 | 1.00 (0.68–1.45) | 0.99 (0.66–1.47) | 0.97 (0.64–1.48) |
15.0–29.9 | 161 | 1,350 | 14 | 10.4 | 1.11 (0.63–1.96) | 1.12 (0.62–2.02) | 1.15 (0.63–2.11) |
≥30.0 | 63 | 537 | 8 | 14.9 | 1.73 (0.84–3.58) | 1.75 (0.82–3.74) | 1.76 (0.77–3.95) |
Women >70 y | |||||||
<5.0 | 526 | 4,149 | 171 | 41.2 | 1.00 | 1.00 | 1.00 |
5.0–14.9 | 294 | 2,382 | 86 | 36.1 | 0.77 (0.60–1.00) | 0.78 (0.60–1.02) | 0.77 (0.58–1.00) |
15.0–29.9 | 104 | 821 | 37 | 45.1 | 0.98 (0.68–1.40) | 0.99 (0.69–1.42) | 0.89 (0.61–1.31) |
≥30.0 | 36 | 261 | 14 | 53.6 | 1.09 (0.62–1.89) | 1.10 (0.63–1.92) | 1.14 (0.65–2.01) |
Crude mortality rate per 1,000 person years.
Model 1: Adjusted for age (continuous) and race.
Model 2: Adjusted for covariates of model 1 and body mass index (continuous).
Model 3: Adjusted for covariates of model 2, smoking status (never, former, current), systolic and diastolic blood pressure, prevalent hypertension, diabetes, and cardiovascular disease.